Biomedical firm and Navy collaborate on hemorrhagic shock drug
05:05 EDT 7 Aug 2012 | SmartBrief
Oxygen Biotherapeutics and the Naval Medical Research Unit of San Antonio agreed to research and develop perfluorocarbon-base -More-
Original Article: Biomedical firm and Navy collaborate on hemorrhagic shock drug
More From BioPortfolio on "Biomedical firm and Navy collaborate on hemorrhagic shock drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
